1-11 of 11
Jiaqiang Ren
Close
Sort by
Journal Articles

Developing a Novel Anti-CD19/CD20 Bi-Specific Chimeric Antigen Receptor T (CAR-T) Cell Therapy for Relapsed/Refractory (r/r) B-Cell NHL

Lili Zhou, MD, Jiaqi Huang, PhD, Shigui Zhu, PhD, Xin Yao, PhD, Shiguang Ye, Judy Zhu, MD, Chengxiao Zheng, MD, Shiyi Chen, Yanfeng Li, MS, Liping Lan, MS, Shicheng Chen, Lin Guo, PhD, Qingsong Zhang, MS, Jiangqin Zheng, Rirfei Wang, MS, Yi Hong, PhD, Jiaqiang Ren, MD PhD, Li Zhang, MD, Wenjun Zhang, MD, Xiaochen Tang, Junbang Wang, Jie Liu, Michael Humphries, MD, Ping Li, MD, Yihong Yao, PhD, Aibin Liang, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 8.
https://doi.org/10.1182/blood-2020-137826
Published: 2020
Journal Articles

Early Clinical Results of a Novel Anti-CD20 Chimeric Antigen Receptor (CAR)-T Cell Therapy for B-Cell NHL Patients Who Are Relapsed/Resistant Following CD19 CAR-T Therapy

Shiguang Ye, Jiaqi Huang, PhD, Shigui Zhu, PhD, Xin Yao, PhD, Lili Zhou, MD, Judy Zhu, MD, Chengxiao Zheng, MD, Shiyi Chen, Liping Lan, MS, Shicheng Chen, Yutian Wei, MS, Wangqin Shu, MS, Chen Ye, Dan Zhang, Rirfei Wang, MS, Yi Hong, PhD, Jiaqiang Ren, MD PhD, Li Zhang, MD, Wenjun Zhang, MD, Xiaochen Tang, Junbang Wang, Jie Liu, Michael Humphries, MD, Ping Li, MD, Yihong Yao, PhD, Aibin Liang, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 8–9.
https://doi.org/10.1182/blood-2020-138538
Published: 2020
Journal Articles

An Anti-Bcma CAR T-Cell Therapy (C-CAR088) Shows Promising Safety and Efficacy Profile in Relapsed or Refractory Multiple Myeloma

Gang An, MD PhD, Weiwei Sui, MD, Tingyu Wang, Xiaoyan Qu, MD PhD, Xian Zhang, MD, Junfang Yang, Yan Zhang, MD, Lu Zhang, MD, Judy Zhu, MD, Chengxiao Zheng, MD, Xiuxiu Yan, Xiaoteng Lv, MS, Liping Lan, MS, Dingzhu Yang, Ningning Huo, Ting Han, MS, Dijun Zhao, MS, Shichao Qin, Junfeng Wu, PhD, Xin Yao, PhD, Shigui Zhu, PhD, Jiaqiang Ren, MD PhD, Li Zhang, MD, Jiaqi Huang, PhD, Michael Humphries, MD, Yihong Yao, PhD, Daobin Zhou, MD PhD, Jianyong Li, MD PhD, Peihua Lu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–30.
https://doi.org/10.1182/blood-2020-138734
Published: 2020
Journal Articles

Developing a Novel Anti-Bcma CAR-T for Relapsed or Refractory Multiple Myeloma

Xin Yao, PhD, Shigui Zhu, PhD, Jiaqi Huang, PhD, Xiaoyan Qu, MD PhD, Judy Zhu, MD, Yutian Wei, MS, Liping Lan, MS, Xiaoteng LV, MS, Junfeng Wu, PhD, Rirfei Wang, MS, Dingzhu Yang, Chengxiao Zheng, MD, DiJun Zhao, MS, Lei Fan, MD PhD, Fei Huang, Hua Lu, MD PhD, Chaocan Zhang, MS, Cheng Chen, PhD, Yanfeng Li, MS, Jiaqiang Ren, MD PhD, Li Zhang, MD, Michael Humphries, MD, Jianyong Li, MD, Yihong Yao, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 50.
https://doi.org/10.1182/blood-2019-125372
Published: 2019
Journal Articles

The Post-Thaw Recovery of Cryopreserved Chimeric Antigen Receptor (CAR) T-Cells during Manufacture Is Better Than That of Cryopreserved Peripheral Blood CD3+ Cells

Nasha Elavia, MD MBBS, Andrew McManus, Steven L Highfill, PhD, Jiaqiang Ren, MD PhD, Nirali N Shah, MD, Terry J. Fry, MD, Jennifer Brudno, MD, James N. Kochenderfer, MD, David Stroncek, MD, Sandhya R. Panch, MDMPH
Journal: Blood
Blood (2017) 130 (Supplement 1): 4475.
https://doi.org/10.1182/blood.V130.Suppl_1.4475.4475
Published: 2017
Journal Articles

CD4/CD8 T-Cell Selection Enhances CD22 CAR-T Cell Transduction and in-Vivo CAR-T Expansion: Updated Results on Phase I Anti-CD22 CAR Dose Expansion Cohort

Nirali N Shah, MD, Steven L Highfill, PhD, Haneen Shalabi, DO, Bonnie Yates, RN, Eli Kane, Vicki Fellowes, Cynthia Delbrook, RN, Jiaqiang Ren, MD PhD, Jianjian Jin, David Stroncek, MD, Terry J. Fry, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 809.
https://doi.org/10.1182/blood.V130.Suppl_1.809.809
Published: 2017
Journal Articles

Gene therapy simplified

Jiaqiang Ren, David F. Stroncek
Journal: Blood
Blood (2016) 128 (18): 2194–2195.
https://doi.org/10.1182/blood-2016-09-736983
Published: 2016
Journal Articles

Myeloid Cells in Peripheral Blood Mononuclear Cell (PMBC) Concentrates Inhibit the Expansion of Chimeric Antigen Receptor (CAR) T Cells

David F. Stroncek, MD, Daniel W. Lee, III, MD, Jiaqiang Ren, MD PhD, Marianna Sabatino, MD, Hanh Khuu, MD, Melinda S. Merchant, MD, Crystal L. Mackall, MD
Journal: Blood
Blood (2015) 126 (23): 383.
https://doi.org/10.1182/blood.V126.23.383.383
Published: 2015
Journal Articles

Tracking Senescence In Human Bone Marrow Stromal Cell (BMSC) Cultures.

Jiaqiang Ren, MD, PhD, David Stroncek, MD, Ping Jin, PhD, Luciano Castiello, PhD, Katherine Tran, Sergei Kuznetsov, PhD, Arun Balakumaran, MD, Harvey G Klein, MD, Pamela Robey, PhD, Marianna Sabatino, MD
Journal: Blood
Blood (2010) 116 (21): 1179.
https://doi.org/10.1182/blood.V116.21.1179.1179
Published: 2010
Journal Articles

Comparative Global Transcriptome Analysis of Bone Marrow Stromal Cells (BMSC), Human Embryonic Stem (hES) Cells and CD34+ Cells.

Ping Jin, Jiaqiang Ren, MD, PhD, Marianna Sabatino, Arun Balakumaran, MD, PhD, Sergei Kuznetsov, PhD, Harvey G. Klein, MD, Pamela G. Robey, PhD, David Stroncek, MD
Journal: Blood
Blood (2009) 114 (22): 36.
https://doi.org/10.1182/blood.V114.22.36.36
Published: 2009
Journal Articles

Plerixafor (AMD3100) and granulocyte colony-stimulating factor (G-CSF) mobilize different CD34 + cell populations based on global gene and microRNA expression signatures

Robert E. Donahue, Ping Jin, Aylin C. Bonifacino, Mark E. Metzger, Jiaqiang Ren, Ena Wang, David F. Stroncek
Journal: Blood
Blood (2009) 114 (12): 2530–2541.
https://doi.org/10.1182/blood-2009-04-214403
Published: 2009